Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00213590 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Renal Function Evaluation After Reduction of Cyclosporine A Dose in Renal Transplant Patients

Study acronym: DICAM
StatusCompleted
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

  1. Study sites: 0 to 1v5
  2. Re-verified, no change to tracked fieldsv4
  3. Trial status: Active, Not Recruiting to Completed Primary completion date: Nov 2006 · Completion date: Jun 2006 to Nov 2006 · Interventions: ciclosporine A (Drug) to cyclosporine A (Drug) · 5 morev3 Show 8 more changesShow less
    • Primary completion date: Nov 2006
    • Completion date: Jun 2006 to Nov 2006
    • Interventions: ciclosporine A (Drug) to cyclosporine A (Drug)
    • Eligibility criteria revised
    • Secondary endpoints revised (15)
    • Study description expanded, about 594 words
    • Study title revised
    • Study arms: 0 to 2

    See this version in full on ClinicalTrials.gov ↗

  4. Completion date: Jun 2006v2
  5. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to show the efficacy of reduction of cyclosporine A exposure measured by the area under the curve by Bayesian estimator on the primary prevention of degradation of the renal function in renal transplant recipients
Trial Details
NCT Number NCT00213590
Lead Sponsor University Hospital, Rouen
Conditions Kidney Transplantation, Primary Prevention, Kidney Failure
Enrollment 208 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov